Wednesday, 26 May 2021

Neurosurgical Products Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

 

Neurosurgery is a medical field related to prevention, diagnosis, and treatment of nervous system disorders and rehabilitation of patients suffering from the disorder post-surgery. Neurosurgery is majorly performed for treating neuro-trauma and intracranial hemorrhage.

Statistics:

The global Neurosurgical Products Market is estimated to account for US$ 13,203.7 Mn in terms of value by the end of 2027.

Global Neurosurgical Products Market: Drivers

Approval and launch of new products is expected to propel growth of the global neurosurgical products market over the forecast period. For instance, in February 2019, Medtronic plc received the U.S. Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline Flex embolization device, for the treatment of small or medium, wide-necked brain aneurysms in the territory from the petrous to the terminus of the internal carotid artery.

Global Neurosurgical Products Market: Opportunities

R&D of new approaches in the treatment of neurological disorders is expected to offer lucrative growth opportunities for players in the global neurological products market. For instance, in May 2020, researchers from Yonsei University College of Medicine, South Korea, reported that gamma knife radiosurgery followed by embolization can be effective in the treatment of ruptured brain arteriovenous malformations that are at risk for obliteration failure and repeat hemorrhage during the latency period after single-session gamma knife radiosurgery alone.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3909

Global Neurosurgical Products Market: Restraints

Stringent regulatory requirements and long approval time for new neurosurgical products is expected to limit growth of the market. For instance, the approval process for stereotactic radiosurgery systems is stringent and time consuming, which delays the entry of new systems into the market. For instance, in the U.S., regulations are implemented by the Food and Drug Administration (FDA), Safe Medical Device Act (SMDA), and Nuclear Regulatory Commission (NRC) Act for radiation safety of external beam therapies.

Key Takeaways:

The global neurosurgical products market was valued at US$ 5,610.4 Mn in 2019 and is forecast to reach a value of US$ 13,203.7 Mn by 2027 at a CAGR of 11.3% between 2020 and 2027. Approval and launch of new products is expected to propel growth of the global neurosurgical products market over the forecast period.

Aneurysms segment held dominant position in the global neurosurgical products market in 2019, accounting for 36.6% share in terms of value, followed by Pituitary and Intracranial tumors, respectively. Increasing research along with increasing patient population is expected to drive the segment growth during the forecast period.

Market Trends

Major players in the market are focused on investing in R&D to expand their product portfolio. For instance, B. Braun Melsungen AG invested US$ 1,366.64 million in the expansion or replacement of production facilities and in research and development in the 2019 fiscal year.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/neurosurgical-products-market-3909

Major players in the market are also focused approval and launch of new products to expand their product portfolio. For instance, in May 2020, Elekta launched Leksell Gamma Knife Lightning, its next-generation stereotactic radiosurgery system.

Global Neurosurgical Products Market: Competitive Landscape  

Major players operating in the global neurosurgical products market include, Integra LifeSciences Holdings Corporation, KARL STORZ GmbH & Co. KG, Medtronic plc, Johnson & Johnson Services, Inc., Stryker Corporation, Elekta AB, Terumo Corporation, Penumbra, Inc., B. Braun Melsungen AG, and Varian Medical Systems, Inc.

Global Neurosurgical Products Market: Key Developments

January 2020: MicroVention, Inc., a U.S. based subsidiary of Terumo Corporation announced the U.S. FDA Premarket Approval for the FRED (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms

January 2020: Terumo Corporation received manufacturing and marketing approval of its Woven EndoBridge Device (WEB) for the treatment of intracranial wide neck bifurcation aneurysms in Japan

September 2018: Medtronic plc launched the Infinity Occipitocervical-Upper Thoracic System designed to simplify posterior cervical spine surgery

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3909

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737


No comments:

Post a Comment